gms | German Medical Science

59. Jahrestagung der Deutschen Gesellschaft für Neurochirurgie (DGNC)
3. Joint Meeting mit der Italienischen Gesellschaft für Neurochirurgie (SINch)

Deutsche Gesellschaft für Neurochirurgie (DGNC) e. V.

01. - 04.06.2008, Würzburg

Reactive cyst formation following the local therapy with Gliadel® in patients with malignant glioma and implications for the treatment

Reaktive Zysten mit einem deutlichen raumfordernden Effekt nach der Implantation von Gliadel Wafern: chirurgische Empfehlungen

Meeting Abstract

Suche in Medline nach

  • corresponding author L. Dörner - Klinik für Neurochirurgie, UKSH Campus Kiel
  • H. M. Mehdorn - Klinik für Neurochirurgie, UKSH Campus Kiel
  • A. Nabavi - Klinik für Neurochirurgie, UKSH Campus Kiel

Deutsche Gesellschaft für Neurochirurgie. Società Italiana di Neurochirurgia. 59. Jahrestagung der Deutschen Gesellschaft für Neurochirurgie e.V. (DGNC), 3. Joint Meeting mit der Italienischen Gesellschaft für Neurochirurgie (SINch). Würzburg, 01.-04.06.2008. Düsseldorf: German Medical Science GMS Publishing House; 2008. DocDI.06.03

Die elektronische Version dieses Artikels ist vollständig und ist verfügbar unter:

Veröffentlicht: 30. Mai 2008

© 2008 Dörner et al.
Dieser Artikel ist ein Open Access-Artikel und steht unter den Creative Commons Lizenzbedingungen ( Er darf vervielfältigt, verbreitet und öffentlich zugänglich gemacht werden, vorausgesetzt dass Autor und Quelle genannt werden.



Objective: Local chemotherapy is increasingly being used in the therapy of malignant gliomas. So far Gliadel ® is the only approved therapeutic. With an increasing use, distinctive side effects of this technique become evident. We report reactive cysts with a significant mass effect and give suggestions for the treatment.

Methods: In our series of 40 patients with malignant gliomas treated with Gliadel ® from 2004 to 2007 we had 5 cases of reactive cyst formation resulting in a clinical relevant mass effect. They occurred on an average 20 days after implantation (median 22, range 11–30).

To reduce intracranial pressure, we prescribed high dose corticosteroids and decompressed the cyst using different surgical techniques. In 3 patients we punctuated the cyst with a cannula through the craniotomy burr hole once or several times, in 3 patients we implanted Ommaya reservoirs for recurrent punctuation and in 3 cases macroscopically opened and decompressed the cyst. Eventually none of the patients died of the raised ICP. Up today two patients died due to the tumor disease. The mean survival time after Gliadel ® implantation is so far 12.4 months (range 6 to 36). In average the cysts were punctuated 2.4 times (median 2, range 1 to 3)

Results: Due to the small number of punctuation per cyst the least invasive approach, transcutaneously with a cannula, can be recommended, when the configuration of the burr hole or the craniotomy gap in relation to the cyst allows doing so. Otherwise or when additional reasons, e.g. a hygroma, appear an Ommaya reservoir implantation or open decompression is a choice.

Conclusions: Reactive cyst formation following Gliadel ® implantation in patients with recurrent malignant glioma is a noteworthy complication and should be cautiously monitored in the following 5 weeks.